TP53 and acute myeloid leukemia: Gene expression signatures annotated as interferon signaling, cell cycle, transcriptional regulation by TP53 and MAPK signaling were significantly enriched in AML donor cells from imetelstat-treated compared to vehicle control-treated PDX (Fig. 2j,k).